Rezolute

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Rezolute and other ETFs, options, and stocks.

About RZLT

Rezolute, Inc. operates as a biopharmaceutical company, which engages in the development of drug therapies for patients with metabolic and orphan diseases. The firm's antibody therapy, ersodetug, is designed to treat all forms of hyperinsulinism.

CEO

Nevan Charles Elam

CEONevan Charles Elam

Employees

Employees71

Headquarters

Redwood City, California

HeadquartersRedwood City, California

Founded

2010

Founded2010

Employees

Employees71

RZLT Key Statistics

Market cap

816.54M

Market cap816.54M

Price-Earnings ratio

-8.64

Price-Earnings ratio-8.64

Dividend yield

—

Dividend yield—

Average volume

1.40M

Average volume1.40M

High today

$9.04

High today$9.04

Low today

$8.47

Low today$8.47

Open price

$8.50

Open price$8.50

Volume

1.36M

Volume1.36M

52 Week high

$9.72

52 Week high$9.72

52 Week low

$2.22

52 Week low$2.22

Analyst ratings

100%

of 10 ratings

Buy

100%

Hold

Sell

People also own

Based on the portfolios of people who own RZLT. This list is generated using Robinhood data, and it’s not a recommendation.

Rezolute

Why Robinhood?

Rezolute, Inc. operates as a biopharmaceutical company, which engages in the development of drug therapies for patients with metabolic and orphan diseases. The firm's antibody therapy, ersodetug, is designed to treat all forms of hyperinsulinism. Show more

RZLT Key Statistics

Analyst ratings

100%

People also own

Rezolute, Inc. operates as a biopharmaceutical company, which engages in the development of drug therapies for patients with metabolic and orphan diseases. The firm's antibody therapy, ersodetug, is designed to treat all forms of hyperinsulinism.